CAeditome Logo

Home

Download

Statistics

Landscape

Help

Contact
Center for Computational Systems Medicine
Soverview

1. Gene summary of enriched editing regions

Soverview

2. Tumor-specific enriched editing regions

Comparison of enriched editing regions between tumor and normal.

Correlation of enriched editing regions with tumor stages.

Associations of enriched editing regions with cancer survival.

Soverview

3. Enriched editing regions and immune related genes

Soverview

4. Enriched editing regions and immune related splicing

Soverview

5. Enriched editing regions and immune infiltration

Soverview

6. Enriched editing regions and immune gene sets

Correlation of enriched editing regions with epithelial-mesenchymal transition.

Correlations of enriched editing regions with hypoxic.

Associations of enriched editing regions with hallmark gene sets from MSigDB.

Soverview

7. Enriched editing regions and drugs

Correlations between enriched editing regions and drug sensitivity.

Enriched editing regions targeted by drugs from DrugBank database.

Editing gene: MAGT1 (ImmuneEditome ID:84061)

1. Gene summary of enriched editing regions for MAGT1

check button Gene summary
Gene informationGene symbol

MAGT1

Gene ID

84061

GeneSynonymsCDG1CC|IAP|MRX95|OST3B|PRO0756|SLC58A1|XMEN|bA217H1.1
GeneCytomap

Xq21.1

GeneTypeprotein-coding
GeneDescriptionmagnesium transporter protein 1|dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit MAGT1|implantation-associated protein|oligosaccharyl transferase subunit MAGT1|oligosaccharyltransferase 3 homolog B
GeneModificationdate20230329
UniprotIDQ9H0U3;A0A087WU53;A0A8I5KY62;A0A8I5QJM4;A0A8I5KYH1;A0A8I5KUC4;A0A8I5QJJ8;A0A8I5QKX7
PubMed ID

check buttonUCSC image.
all structure

check buttonLocations of each EERs.
EERENSTENSGGeneNameRegionRepeatdsRNA structure
chrX:77827453-77828594:-ENST00000358075.9ENSG00000102158.18MAGT1UTR3AluSz,AluSg,AluSz6chrX:77827453-77828594:-.alignment
chrX:77827453-77828594:-ENST00000610432.3ENSG00000102158.18MAGT1UTR3AluSz,AluSg,AluSz6chrX:77827453-77828594:-.alignment
chrX:77827453-77828594:-ENST00000618282.3ENSG00000102158.18MAGT1UTR3AluSz,AluSg,AluSz6chrX:77827453-77828594:-.alignment
chrX:77848889-77851696:-ENST00000358075.9ENSG00000102158.18MAGT1intronicAluSx1,L1ME3A,AluJo,AluSx,AluSz6chrX:77848889-77851696:-.alignment
chrX:77848889-77851696:-ENST00000610432.3ENSG00000102158.18MAGT1intronicAluSx1,L1ME3A,AluJo,AluSx,AluSz6chrX:77848889-77851696:-.alignment
chrX:77848889-77851696:-ENST00000618282.3ENSG00000102158.18MAGT1intronicAluSx1,L1ME3A,AluJo,AluSx,AluSz6chrX:77848889-77851696:-.alignment


Top

2. Tumor-specific enriched editing regions for MAGT1


all structure

check buttonComparison of enriched editing regions between tumor and normal.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypePBoxplot
chrX:77827453-77828594:-BRCAEER3.4313e-40image
ENSG00000102158.18,MAGT1BRCAEAG2.4971e-40image
chrX:77827453-77828594:-COADEER1.0647e-08image
ENSG00000102158.18,MAGT1COADEAG6.5631e-09image
chrX:77827453-77828594:-HNSCEER2.5615e-13image
ENSG00000102158.18,MAGT1HNSCEAG2.5615e-13image
chrX:77827453-77828594:-KICHEER3.1957e-10image
ENSG00000102158.18,MAGT1KICHEAG3.1957e-10image
chrX:77827453-77828594:-KIRCEER1.2636e-04image
ENSG00000102158.18,MAGT1KIRCEAG9.2309e-05image
chrX:77827453-77828594:-LUADEER7.4387e-06image
ENSG00000102158.18,MAGT1LUADEAG7.5286e-06image
chrX:77827453-77828594:-STADEER2.4063e-02image
ENSG00000102158.18,MAGT1STADEAG2.3196e-02image
chrX:77827453-77828594:-THCAEER4.5250e-04image
ENSG00000102158.18,MAGT1THCAEAG4.5250e-04image
chrX:77827453-77828594:-UCECEER9.3221e-04image
ENSG00000102158.18,MAGT1UCECEAG6.6608e-04image


Top

check buttonCorrelation of enriched editing regions with tumor stages.
* AnovaP<0.05, Pearson P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes, Path: Pathological stage, Cli: Clinical stage.
* Only shows the most significant correlation result of EERs/EAGs with either pathological stage or clinical stage according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeStageTypeAnovaPPRBoxplot
ENSG00000102158.18,MAGT1TGCTPathEAG2.0511e-029.3850e-03-0.2943image
chrX:77827453-77828594:-TGCTPathEER2.0511e-029.3850e-03-0.2943image
ENSG00000102158.18,MAGT1THCAPathEAG2.0435e-024.8675e-030.1256image
chrX:77827453-77828594:-THCAPathEER2.0435e-024.8675e-030.1256image
ENSG00000102158.18,MAGT1UVMCliEAG2.2111e-022.3195e-020.2602image
chrX:77827453-77828594:-UVMCliEER2.2111e-022.3195e-020.2602image


Top

check button Associations of enriched editing regions with cancer survival.
* Pkm<0.05 and Pcox<0.05.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypeIDPkmPcox_continuousHR_continuousKMPlot

Top

3. Enriched editing regions and immune related genes for MAGT1


all structure

check button Enriched editing regions and immune related genes.
* First, the associations between enriched editing regions and genes were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the gene relationships with immune were tested by three analyses: whether the gene is an immune gene (InnateDB、Immport、Immunome、Immunogenetic Related Information Source (IRIS)), whether the gene is associated with immune infiltration and whether the gene is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of genes with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeGenebetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
chrX:77827453-77828594:-UCECEERENSG00000187608,ISG150.52911.9281e-085.8484e-080.4024imageNNISG15T_cells_CD4_memory_restingGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000156587,UBE2L60.52204.2547e-081.2554e-080.4205imageNNNAMacrophages_M1GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000204267,TAP20.51144.2547e-082.5052e-120.5051imageNNTAP2Macrophages_M1GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000130303,BST20.50781.5244e-072.6153e-110.4840imageNNBST2T_cells_regulatory_(Tregs)GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000142089,IFITM30.50521.7106e-073.1876e-100.4598imageNNIFITM3Macrophages_M1GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000165949,IFI270.49882.2177e-071.5058e-110.4891imageNNIFI27T_cells_CD4_memory_restingGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000068079,IFI350.48923.9216e-078.9366e-150.5505imageNNIFI35T_cells_CD8GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000135899,SP1100.49145.4163e-071.5711e-080.4179imageNNSP110Macrophages_M1GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000140105,WARS0.48777.6536e-071.2969e-120.5108imageNNWARST_cells_CD4_memory_activatedGSVA_HALLMARK_INTERFERON_GAMMA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000059378,PARP120.47891.3890e-065.1031e-080.4040imageNNNAMacrophages_M1GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000187608,ISG150.52911.9281e-085.8484e-080.4024imageNNISG15T_cells_CD4_memory_restingGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000156587,UBE2L60.52204.2547e-081.2554e-080.4205imageNNNAMacrophages_M1GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000204267,TAP20.51144.2547e-082.5052e-120.5051imageNNTAP2Macrophages_M1GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000130303,BST20.50781.5244e-072.6153e-110.4840imageNNBST2T_cells_regulatory_(Tregs)GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000142089,IFITM30.50521.7106e-073.1876e-100.4598imageNNIFITM3Macrophages_M1GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000165949,IFI270.49882.2177e-071.5058e-110.4891imageNNIFI27T_cells_CD4_memory_restingGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000068079,IFI350.48923.9216e-078.9366e-150.5505imageNNIFI35T_cells_CD8GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000135899,SP1100.49145.4163e-071.5711e-080.4179imageNNSP110Macrophages_M1GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000140105,WARS0.48777.6536e-071.2969e-120.5108imageNNWARST_cells_CD4_memory_activatedGSVA_HALLMARK_INTERFERON_GAMMA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000059378,PARP120.47891.3890e-065.1031e-080.4040imageNNNAMacrophages_M1GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000187608,ISG150.52911.9281e-085.8484e-080.4024imageNNISG15T_cells_CD4_memory_restingGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000156587,UBE2L60.52204.2547e-081.2554e-080.4205imageNNNAMacrophages_M1GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000204267,TAP20.51144.2547e-082.5052e-120.5051imageNNTAP2Macrophages_M1GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000130303,BST20.50781.5244e-072.6153e-110.4840imageNNBST2T_cells_regulatory_(Tregs)GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000142089,IFITM30.50521.7106e-073.1876e-100.4598imageNNIFITM3Macrophages_M1GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000165949,IFI270.49882.2177e-071.5058e-110.4891imageNNIFI27T_cells_CD4_memory_restingGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000068079,IFI350.48923.9216e-078.9366e-150.5505imageNNIFI35T_cells_CD8GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000135899,SP1100.49145.4163e-071.5711e-080.4179imageNNSP110Macrophages_M1GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000140105,WARS0.48777.6536e-071.2969e-120.5108imageNNWARST_cells_CD4_memory_activatedGSVA_HALLMARK_INTERFERON_GAMMA_RESPONSE
chrX:77827453-77828594:-UCECEERENSG00000059378,PARP120.47891.3890e-065.1031e-080.4040imageNNNAMacrophages_M1GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE

More results



Top

4. Enriched editing regions and immune related splicing for MAGT1


all structure

check button Enriched editing regions and immune related splicing.
* First, the associations between enriched editing regions and splicing events were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the splicing relationships with immune were tested by three analyses: whether the splicing event locates in an immune gene (InnateDB、Immport, Immunome and Immunogenetic Related Information Source (IRIS)), whether the splicing event is associated with immune infiltration and whether the splicing event is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of splicing events with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeSplicingTypeSplicingGeneSplicingChrSplicingPositionbetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
ENSG00000102158.18,MAGT1
COADEAGMEXENSG00000145495.10chr510394752:10394785:10397292:10397307:10400837:10400842:10402058:10402139-0.29129.9154e-042.0460e-19-0.5068imageNACIN1;ADAR;AIFM1;ALYREF;AUH;BCCIP;BUD13;CBX7;CELF2;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;DICER1;DKC1;EIF4A3;ELAVL1;ELAVL3;EWSR1;FAM120A;FBL;FMR1;FTO;FUS;FXR1;FXR2;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPD;HNRNPK;HNRNPL;HNRNPM;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;KHDRBS1;KHDRBS2;KHDRBS3;KHSRP;LARP7;LIN28;LIN28A;LIN28B;LSM11;MBNL2;MOV10;MSI1;MSI2;NONO;NOP56;NOP58;NPM1;NUMA1;PCBP2;PRPF8;PTBP1;QKI;RANGAP1;RBFOX2;RBM10;RBM22;RBM27;RBM47;RBM5;RBM6;RNF219;SAFB2;SF3A3;SLBP;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARBP2;TARDBP;TIA1;TIAL1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;VIM;WTAP;XRN2;YTHDC1;YTHDF1;YWHAG;ZNF184NADendritic_cells_activatedGSVA_HALLMARK_INFLAMMATORY_RESPONSE
ENSG00000102158.18,MAGT1
COADEAGA3ENSG00000188373.4chr1084176452:84176569:84184850:84185284:84184680:841852840.20794.1239e-022.4034e-260.6128imageNADAR;DGCR8;DKC1;EIF4A3;ELAVL1;FBL;FUS;HNRNPL;NOP56;NOP58;UPF1NADendritic_cells_activatedGSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALING
ENSG00000102158.18,MAGT1
COADEAGESENSG00000159023.14chr129053106:29053312:29058588:29058645:29064981:29065158-0.24603.3284e-032.8555e-10-0.4013imageNACIN1;ADAR;AIFM1;ALYREF;AUH;BCCIP;BUD13;CBX7;CELF2;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;DICER1;DKC1;EIF4A3;ELAVL1;ELAVL3;EWSR1;FAM120A;FBL;FMR1;FTO;FUS;FXR1;FXR2;GTF2F1;HNRNPA1;HNRNPC;HNRNPD;HNRNPK;HNRNPL;HNRNPM;HNRNPU;IGF2BP1;IGF2BP2;IGF2BP3;KHDRBS1;KHDRBS2;KHDRBS3;KHSRP;LARP7;LIN28;LIN28A;LIN28B;LSM11;MBNL2;MOV10;MSI1;MSI2;NONO;NOP56;NOP58;NPM1;NUMA1;PCBP2;PRPF8;PTBP1;QKI;RANGAP1;RBFOX2;RBM10;RBM22;RBM27;RBM47;RBM5;SF3A3;SLBP;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARBP2;TARDBP;TIA1;TIAL1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;VIM;XRN2;YTHDC1;YTHDF1;YWHAG;ZNF184NANeutrophilsGSVA_HALLMARK_ALLOGRAFT_REJECTION
ENSG00000102158.18,MAGT1
COADEAGIRENSG00000115419.8chr2190921144:190921203:190923916:1909239830.24131.5841e-021.4095e-320.6351imageNACIN1;ADAR;AIFM1;ALYREF;AUH;BCCIP;BUD13;CELF2;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;DICER1;DKC1;EIF4A3;ELAVL1;ELAVL3;EWSR1;FAM120A;FBL;FMR1;FTO;FUS;FXR1;FXR2;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPD;HNRNPK;HNRNPL;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;KHDRBS1;KHDRBS2;KHDRBS3;KHSRP;LARP7;LIN28;LIN28A;LIN28B;LSM11;MBNL2;MOV10;MSI1;MSI2;NONO;NOP56;NOP58;NPM1;NUMA1;PCBP2;PRPF8;PTBP1;QKI;RANGAP1;RBFOX2;RBM10;RBM22;RBM27;RBM47;RBM5;RBM6;RNF219;SAFB2;SF3A3;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TIAL1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;VIM;XRN2;YTHDC1;YTHDF1;YWHAG;ZNF184NADendritic_cells_activatedGSVA_HALLMARK_UV_RESPONSE_UP
ENSG00000102158.18,MAGT1
COADEAGMEXENSG00000115966.12chr2175093060:175093267:175097443:175097593:175114817:175114868:175117989:175118118-0.22593.4373e-022.9239e-12-0.4040imageNACIN1;ADAR;AIFM1;ALYREF;AUH;BCCIP;BUD13;CELF2;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;DICER1;DKC1;EIF4A3;ELAVL1;ELAVL3;EWSR1;FAM120A;FBL;FMR1;FUS;FXR2;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPD;HNRNPK;HNRNPL;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;KHDRBS1;KHDRBS2;KHDRBS3;KHSRP;LARP7;LIN28;LIN28A;LIN28B;MBNL2;MOV10;MSI1;MSI2;NONO;NOP56;NOP58;NPM1;NUMA1;PCBP2;PRPF8;PTBP1;QKI;RANGAP1;RBFOX2;RBM10;RBM22;RBM27;RBM47;RNF219;SF3A3;SLBP;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARBP2;TARDBP;TIA1;TIAL1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YTHDC1;YWHAG;ZNF184ATF2EosinophilsGSVA_HALLMARK_P53_PATHWAY
ENSG00000102158.18,MAGT1
COADEAGIRENSG00000048740.13chr1011328925:11329097:11330455:113306390.37021.1407e-063.1920e-120.4153imageNADAR;AIFM1;CBX7;CELF2;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DGCR8;DHX9;DICER1;DKC1;EIF4A3;ELAVL1;ELAVL3;EWSR1;FAM120A;FBL;FMR1;FTO;FUS;FXR1;FXR2;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPD;HNRNPK;HNRNPL;HNRNPM;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;KHDRBS1;KHDRBS2;KHDRBS3;KHSRP;LIN28;LIN28A;LIN28B;MBNL2;MOV10;MSI1;MSI2;NONO;NOP56;NOP58;NPM1;PRPF8;PTBP1;QKI;RANGAP1;RBFOX2;RBM10;RBM47;RBM5;SLTM;SMNDC1;SND1;SRSF1;SRSF3;TAF15;TARDBP;TIA1;TNRC6A;TROVE2;U2AF1;U2AF2;UPF1;WTAP;YTHDC1NAMacrophages_M0GSVA_HALLMARK_PEROXISOME
ENSG00000102158.18,MAGT1
COADEAGIRENSG00000116679.11chr1185301433:185306625:185307013:1853071390.21904.1970e-021.2620e-210.5385imageNACIN1;ADAR;AIFM1;ALYREF;AUH;BCCIP;BUD13;CBX7;CELF2;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;DICER1;DKC1;EIF4A3;ELAVL1;ELAVL3;EWSR1;FAM120A;FBL;FMR1;FTO;FUS;FXR1;FXR2;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPD;HNRNPK;HNRNPL;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;KHDRBS1;KHDRBS2;KHDRBS3;KHSRP;LARP7;LIN28;LIN28A;LIN28B;LSM11;MBNL2;MOV10;MSI1;MSI2;NONO;NOP56;NOP58;NPM1;NUMA1;PCBP2;PRPF8;PTBP1;QKI;RANGAP1;RBFOX2;RBM10;RBM22;RBM27;RBM47;RNF219;SAFB2;SF3A3;SLBP;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TIAL1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;VIM;WTAP;XRN2;YTHDC1;YWHAG;ZNF184NANeutrophilsGSVA_HALLMARK_PEROXISOME
ENSG00000102158.18,MAGT1
COADEAGMEXENSG00000103534.12chr1619481369:19481465:19486944:19487326:19490460:19490568:19492149:194922280.24181.6569e-025.8443e-130.4157imageNACIN1;ADAR;ALYREF;CSTF2T;DDX3X;DDX54;DGCR8;DHX9;DKC1;EIF4A3;ELAVL1;FBL;FMR1;FTO;FUS;HNRNPA1;HNRNPC;HNRNPK;HNRNPL;IGF2BP2;IGF2BP3;LSM11;MOV10;NONO;NOP56;NOP58;PCBP2;PRPF8;PTBP1;SF3A3;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TROVE2;U2AF2;UPF1;WTAP;YTHDC1;YWHAG;ZNF184NANeutrophilsGSVA_HALLMARK_DNA_REPAIR
ENSG00000102158.18,MAGT1
COADEAGIRENSG00000138185.12chr1095844475:95844635:95845356:958455960.25431.2426e-039.5669e-120.4304imageNADAR;DGCR8;DKC1;EIF4A3;ELAVL1;ELAVL3;EWSR1;FBL;FMR1;FUS;FXR1;HNRNPA1;HNRNPL;HNRNPM;IGF2BP2;IGF2BP3;MBNL2;MOV10;MSI1;NOP56;NOP58;PTBP1;RBFOX2;SAFB2;SRSF1;SRSF3;TAF15;TARDBP;TROVE2;U2AF2;UPF1ENTPD1EosinophilsGSVA_HALLMARK_ESTROGEN_RESPONSE_LATE
ENSG00000102158.18,MAGT1
COADEAGA5ENSG00000008517.12chr163065780:3065826:3065609:3065655:3065609:3065710-0.31201.4021e-046.4417e-13-0.4288imageNACIN1;ADAR;AUH;BCCIP;BUD13;CELF2;CSTF2T;DGCR8;EIF4A3;ELAVL1;FAM120A;FTO;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPL;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;KHSRP;LARP7;LIN28B;MBNL2;MOV10;NOP56;NUMA1;PCBP2;PRPF8;RANGAP1;RBFOX2;SF3A3;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARBP2;TARDBP;TIA1;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;WTAP;XRN2IL32EosinophilsGSVA_HALLMARK_COMPLEMENT

More results



Top

5. Enriched editing regions and immune infiltration for MAGT1


all structure

check button Associations of enriched editing regions with immune infiltration.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the fraction of different immune cells according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeIDImmuneCellPRCorrelationPlot
chrX:77827453-77828594:-ACCEERT_cells_regulatory_(Tregs)2.8524e-030.3444image
ENSG00000102158.18,MAGT1ACCEAGT_cells_regulatory_(Tregs)3.1618e-040.4073image
chrX:77827453-77828594:-BLCAEERMacrophages_M14.5289e-110.3219image
ENSG00000102158.18,MAGT1BLCAEAGMacrophages_M14.5320e-110.3219image
chrX:77827453-77828594:-BRCAEERMacrophages_M12.2644e-030.0928image
ENSG00000102158.18,MAGT1BRCAEAGB_cells_naive2.2771e-03-0.0928image
chrX:77827453-77828594:-CESCEERMacrophages_M03.8836e-06-0.2626image
ENSG00000102158.18,MAGT1CESCEAGMacrophages_M03.8836e-06-0.2626image
chrX:77827453-77828594:-COADEERMacrophages_M12.5308e-050.2506image
ENSG00000102158.18,MAGT1COADEAGDendritic_cells_activated4.1342e-060.2731image
chrX:77827453-77828594:-DLBCEERNK_cells_activated1.0555e-030.4722image
ENSG00000102158.18,MAGT1DLBCEAGNK_cells_activated1.0555e-030.4722image
chrX:77827453-77828594:-ESCAEERMonocytes1.5809e-02-0.1899image
ENSG00000102158.18,MAGT1ESCAEAGMonocytes1.8024e-02-0.1862image
chrX:77827453-77828594:-GBMEERMacrophages_M05.3766e-07-0.3763image
ENSG00000102158.18,MAGT1GBMEAGMacrophages_M05.3766e-07-0.3763image
chrX:77827453-77828594:-HNSCEERMacrophages_M18.1769e-110.2874image
ENSG00000102158.18,MAGT1HNSCEAGMacrophages_M18.1769e-110.2874image
chrX:77827453-77828594:-KICHEERT_cells_CD4_memory_activated4.4463e-020.2521image
ENSG00000102158.18,MAGT1KICHEAGT_cells_CD4_memory_activated4.4463e-020.2521image
chrX:77827453-77828594:-KIRCEERT_cells_CD83.0182e-040.1834image
ENSG00000102158.18,MAGT1KIRCEAGT_cells_CD82.9915e-040.1836image
chrX:77827453-77828594:-LAMLEERMacrophages_M23.6261e-040.2902image
ENSG00000102158.18,MAGT1LAMLEAGMacrophages_M26.0145e-030.2256image
chrX:77827453-77828594:-LGGEERMonocytes3.6179e-050.1794image
ENSG00000102158.18,MAGT1LGGEAGMonocytes2.9268e-050.1813image
chrX:77827453-77828594:-LIHCEERMacrophages_M11.2167e-060.2522image
ENSG00000102158.18,MAGT1LIHCEAGMacrophages_M11.1222e-060.2530image
chrX:77827453-77828594:-LUADEERT_cells_CD81.3548e-030.1408image
ENSG00000102158.18,MAGT1LUADEAGT_cells_CD81.3597e-030.1408image
chrX:77827453-77828594:-LUSCEERMacrophages_M12.0954e-080.2478image
ENSG00000102158.18,MAGT1LUSCEAGMacrophages_M12.0954e-080.2478image
chrX:77827453-77828594:-MESOEERMacrophages_M11.2813e-020.2738image
ENSG00000102158.18,MAGT1MESOEAGMacrophages_M11.2813e-020.2738image
chrX:77827453-77828594:-OVEERMacrophages_M14.0828e-050.2381image
ENSG00000102158.18,MAGT1OVEAGMacrophages_M13.3865e-050.2405image
chrX:77827453-77828594:-PAADEERMast_cells_resting6.6961e-04-0.2533image
ENSG00000102158.18,MAGT1PAADEAGMast_cells_resting6.6961e-04-0.2533image
chrX:77827453-77828594:-PCPGEERT_cells_regulatory_(Tregs)1.1965e-020.1896image
ENSG00000102158.18,MAGT1PCPGEAGT_cells_regulatory_(Tregs)1.1965e-020.1896image
chrX:77827453-77828594:-PRADEERT_cells_regulatory_(Tregs)1.1598e-030.1456image
ENSG00000102158.18,MAGT1PRADEAGT_cells_regulatory_(Tregs)1.4961e-030.1424image
chrX:77827453-77828594:-READEERT_cells_CD4_memory_activated1.0752e-02-0.2606image
ENSG00000102158.18,MAGT1READEAGT_cells_CD4_memory_activated1.0752e-02-0.2606image
chrX:77827453-77828594:-SARCEERMacrophages_M12.0852e-060.2938image
ENSG00000102158.18,MAGT1SARCEAGMacrophages_M12.0852e-060.2938image
chrX:77827453-77828594:-SKCMEERT_cells_CD88.9305e-160.3619image
ENSG00000102158.18,MAGT1SKCMEAGT_cells_CD85.2747e-160.3646image
chrX:77827453-77828594:-STADEERMacrophages_M12.2178e-040.1909image
chrX:77848889-77851696:-STADEEREosinophils3.2675e-020.3727image
ENSG00000102158.18,MAGT1STADEAGMacrophages_M11.6275e-040.1948image
chrX:77827453-77828594:-TGCTEERMacrophages_M26.7753e-07-0.3913image
ENSG00000102158.18,MAGT1TGCTEAGMacrophages_M26.7753e-07-0.3913image
chrX:77827453-77828594:-THCAEERNK_cells_activated1.2965e-02-0.1108image
ENSG00000102158.18,MAGT1THCAEAGNK_cells_activated1.2965e-02-0.1108image
chrX:77827453-77828594:-THYMEERMast_cells_resting3.5409e-040.3469image
ENSG00000102158.18,MAGT1THYMEAGMast_cells_resting3.5409e-040.3469image
chrX:77827453-77828594:-UCECEERT_cells_CD4_memory_resting1.8519e-04-0.2837image
ENSG00000102158.18,MAGT1UCECEAGT_cells_CD4_memory_resting4.2767e-04-0.2672image
chrX:77827453-77828594:-UVMEERT_cells_CD4_memory_resting5.8713e-03-0.3132image
ENSG00000102158.18,MAGT1UVMEAGT_cells_CD4_memory_resting5.8713e-03-0.3132image


Top

6. Enriched editing regions and immune gene sets for MAGT1


all structure

check button Correlation of enriched editing regions with epithelial-mesenchymal transition.
* First, the differences of enriched editing regions between Epi and Mes groups (defined by KS-test) were compared (P<0.05 and Informative number >=20).
* Second, the correlations between enriched editing regions and gene set score of HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly edited between Epi and Mes group.
ID_eventscancerTypeE2M_PBoxplotCorPCorRCorrelationPlot
chrX:77827453-77828594:-BRCAEER3.7921e-02image3.8020e-02-0.0632image
chrX:77827453-77828594:-HNSCEER2.0258e-02image1.8409e-020.1062image
ENSG00000102158.18,MAGT1HNSCEAG2.0258e-02image1.8409e-020.1062image
chrX:77827453-77828594:-LUSCEER4.2089e-03image5.4236e-040.1544image
ENSG00000102158.18,MAGT1LUSCEAG4.2089e-03image5.4236e-040.1544image


Top

check button Correlations of enriched editing regions with hypoxic.
* First, there are four hypoxia scores used in the database. The first three hypoxic scores were calculated on three gene sets of Buffa, Ragnum and Winter based on one previous study (PMID: 32024819). One last hypoxia score was defined on HALLMARK_HYPOXIA by GSVA method.
* Second, the correlations enriched editing regions with the four hypoxic scores were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly correlated with all four hypoxia gene set scores. For more results, please go to download page.
ID_eventscancerTypeBuffa_P Buffa_R Ragnum_P Ragnum_R Winter_P Winter_R HALLMARK_P HALLMARK_R CorrelationPlot
chrX:77827453-77828594:-BLCAEER1.2556e-040.19083.1763e-040.17943.5663e-030.14567.8435e-050.1964image
ENSG00000102158.18,MAGT1BLCAEAG1.2570e-040.19083.1728e-040.17943.5648e-030.14567.8752e-050.1963image
chrX:77827453-77828594:-LUADEER6.0891e-040.15052.6451e-040.16013.8231e-040.15596.3272e-030.1202image
ENSG00000102158.18,MAGT1LUADEAG6.2665e-040.15022.7460e-040.15973.8716e-040.15586.4573e-030.1199image
chrX:77827453-77828594:-PAADEER2.3782e-060.34613.7121e-060.33983.0646e-040.26824.9773e-050.3000image
ENSG00000102158.18,MAGT1PAADEAG2.3782e-060.34613.7121e-060.33983.0646e-040.26824.9773e-050.3000image


Top

check button Associations of enriched editing regions with hallmark gene sets from MSigDB.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerHallmarkTypeTypePRCorrelationPlot
ENSG00000102158.18,MAGT1ACCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG3.7969e-030.3325image
chrX:77827453-77828594:-ACCGSVA_HALLMARK_SPERMATOGENESISEER6.9189e-03-0.3135image
chrX:77827453-77828594:-BLCAGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER5.0090e-160.3910image
ENSG00000102158.18,MAGT1BLCAGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG5.0527e-160.3910image
ENSG00000102158.18,MAGT1BRCAGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG5.2416e-210.2807image
chrX:77827453-77828594:-BRCAGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER4.4791e-220.2881image
ENSG00000102158.18,MAGT1CESCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG1.2736e-210.5132image
chrX:77827453-77828594:-CESCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER1.2736e-210.5132image
chrX:77827453-77828594:-COADGSVA_HALLMARK_INTERFERON_GAMMA_RESPONSEEER1.2508e-100.3747image
ENSG00000102158.18,MAGT1COADGSVA_HALLMARK_PEROXISOMEEAG7.7492e-08-0.3165image
chrX:77827453-77828594:-DLBCGSVA_HALLMARK_PANCREAS_BETA_CELLSEER1.1332e-030.4697image
ENSG00000102158.18,MAGT1DLBCGSVA_HALLMARK_PANCREAS_BETA_CELLSEAG1.1332e-030.4697image
chrX:77827453-77828594:-ESCAGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER1.8944e-070.3967image
ENSG00000102158.18,MAGT1ESCAGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG2.2034e-070.3947image
chrX:77827453-77828594:-GBMGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER2.5861e-080.4144image
ENSG00000102158.18,MAGT1GBMGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG2.5861e-080.4144image
ENSG00000102158.18,MAGT1HNSCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG4.0909e-350.5179image
chrX:77827453-77828594:-HNSCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER4.0909e-350.5179image
chrX:77827453-77828594:-KICHGSVA_HALLMARK_TGF_BETA_SIGNALINGEER3.8909e-03-0.3560image
ENSG00000102158.18,MAGT1KICHGSVA_HALLMARK_TGF_BETA_SIGNALINGEAG3.8909e-03-0.3560image
ENSG00000102158.18,MAGT1KIRCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG9.0805e-110.3229image
chrX:77827453-77828594:-KIRCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER8.8459e-110.3231image
chrX:77827453-77828594:-KIRPGSVA_HALLMARK_PROTEIN_SECRETIONEER6.4480e-04-0.2030image
ENSG00000102158.18,MAGT1KIRPGSVA_HALLMARK_PROTEIN_SECRETIONEAG6.4480e-04-0.2030image
chrX:77827453-77828594:-LAMLGSVA_HALLMARK_ANDROGEN_RESPONSEEER1.3564e-03-0.2619image
ENSG00000102158.18,MAGT1LAMLGSVA_HALLMARK_ANDROGEN_RESPONSEEAG1.5575e-03-0.2587image
chrX:77827453-77828594:-LGGGSVA_HALLMARK_MYOGENESISEER9.3038e-080.2307image
ENSG00000102158.18,MAGT1LGGGSVA_HALLMARK_BILE_ACID_METABOLISMEAG3.5730e-070.2200image
ENSG00000102158.18,MAGT1LIHCGSVA_HALLMARK_BILE_ACID_METABOLISMEAG1.0856e-160.4179image
chrX:77827453-77828594:-LIHCGSVA_HALLMARK_BILE_ACID_METABOLISMEER6.0628e-170.4210image
ENSG00000102158.18,MAGT1LUADGSVA_HALLMARK_UNFOLDED_PROTEIN_RESPONSEEAG8.8492e-070.2146image
chrX:77827453-77828594:-LUADGSVA_HALLMARK_UNFOLDED_PROTEIN_RESPONSEEER8.3825e-070.2150image
chrX:77827453-77828594:-LUSCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER9.8185e-320.4921image
ENSG00000102158.18,MAGT1LUSCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG9.8185e-320.4921image
chrX:77827453-77828594:-MESOGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER3.3817e-020.2347image
ENSG00000102158.18,MAGT1MESOGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG3.3817e-020.2347image
chrX:77827453-77828594:-OVGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER3.0840e-170.4679image
ENSG00000102158.18,MAGT1OVGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG1.5107e-170.4720image
ENSG00000102158.18,MAGT1PAADGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG9.3424e-080.3882image
chrX:77827453-77828594:-PAADGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER9.3424e-080.3882image
ENSG00000102158.18,MAGT1PCPGGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG2.4672e-030.2275image
chrX:77827453-77828594:-PCPGGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER2.4672e-030.2275image
chrX:77827453-77828594:-PRADGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER1.0698e-120.3128image
ENSG00000102158.18,MAGT1PRADGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG9.6510e-120.2998image
chrX:77827453-77828594:-READGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER3.6424e-090.5599image
ENSG00000102158.18,MAGT1READGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG3.6424e-090.5599image
ENSG00000102158.18,MAGT1SARCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG1.1750e-090.3713image
chrX:77827453-77828594:-SARCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER1.1750e-090.3713image
ENSG00000102158.18,MAGT1SKCMGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG2.4061e-140.3445image
chrX:77827453-77828594:-SKCMGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER2.3776e-140.3445image
ENSG00000102158.18,MAGT1STADGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG4.0662e-090.2997image
chrX:77827453-77828594:-STADGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER1.6597e-090.3068image
ENSG00000102158.18,MAGT1TGCTGSVA_HALLMARK_GLYCOLYSISEAG1.7266e-06-0.3778image
chrX:77827453-77828594:-TGCTGSVA_HALLMARK_GLYCOLYSISEER1.7266e-06-0.3778image
chrX:77827453-77828594:-THCAGSVA_HALLMARK_ANDROGEN_RESPONSEEER6.0218e-070.2205image
ENSG00000102158.18,MAGT1THCAGSVA_HALLMARK_ANDROGEN_RESPONSEEAG6.0218e-070.2205image
chrX:77827453-77828594:-THYMGSVA_HALLMARK_KRAS_SIGNALING_DNEER1.5051e-070.4920image
ENSG00000102158.18,MAGT1THYMGSVA_HALLMARK_KRAS_SIGNALING_DNEAG1.5051e-070.4920image
chrX:77827453-77828594:-UCECGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER1.4441e-070.3912image
ENSG00000102158.18,MAGT1UCECGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG4.6053e-060.3432image
chrX:77827453-77828594:-UCSGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER1.2701e-040.4899image
ENSG00000102158.18,MAGT1UCSGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG1.3007e-040.4892image
ENSG00000102158.18,MAGT1UVMGSVA_HALLMARK_KRAS_SIGNALING_DNEAG7.6384e-050.4378image
chrX:77827453-77828594:-UVMGSVA_HALLMARK_KRAS_SIGNALING_DNEER7.6384e-050.4378image


Top

7. Enriched editing regions and drugs for MAGT1


all structure

check button Correlations between enriched editing regions and drug sensitivity.
* First, the drug sensitivity (IS50) was estimated on 84 drugs by pRRophetic package.
* Second, the correlations between editing enriched regions and drug sensitivity were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the IS50 scores of 84 drugs according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerDrugTypePRCorrelationPlot
ENSG00000102158.18,MAGT1ACCABT.263EAG4.5575e-020.2332image
chrX:77827453-77828594:-ACCABT.263EER2.7311e-020.2584image
ENSG00000102158.18,MAGT1BLCACGP.60474EAG2.2846e-09-0.2935image
chrX:77827453-77828594:-BLCACGP.60474EER2.2700e-09-0.2935image
ENSG00000102158.18,MAGT1BRCAJNK.Inhibitor.VIIIEAG1.4800e-08-0.1714image
chrX:77827453-77828594:-BRCACHIR.99021EER2.2271e-080.1693image
ENSG00000102158.18,MAGT1CESCABT.888EAG2.1422e-07-0.2936image
chrX:77827453-77828594:-CESCABT.888EER2.1422e-07-0.2936image
ENSG00000102158.18,MAGT1CHOLA.770041EAG1.4556e-02-0.4096image
chrX:77827453-77828594:-CHOLA.770041EER1.4556e-02-0.4096image
chrX:77827453-77828594:-COADGefitinibEER1.7445e-11-0.3904image
ENSG00000102158.18,MAGT1COADGefitinibEAG4.2742e-11-0.3834image
chrX:77827453-77828594:-DLBCAZ628EER4.0348e-04-0.5050image
ENSG00000102158.18,MAGT1DLBCAZ628EAG4.0348e-04-0.5050image
chrX:77827453-77828594:-ESCAEHT.1864EER9.9525e-030.2026image
ENSG00000102158.18,MAGT1ESCAGDC.0449EAG8.0652e-03-0.2088image
chrX:77827453-77828594:-GBMGefitinibEER1.5569e-09-0.4459image
ENSG00000102158.18,MAGT1GBMGefitinibEAG1.5569e-09-0.4459image
ENSG00000102158.18,MAGT1HNSCAZD6244EAG4.7208e-16-0.3553image
chrX:77827453-77828594:-HNSCAZD6244EER4.7208e-16-0.3553image
chrX:77827453-77828594:-KICHAKT.inhibitor.VIIIEER2.1125e-030.3774image
ENSG00000102158.18,MAGT1KICHAKT.inhibitor.VIIIEAG2.1125e-030.3774image
chrX:77827453-77828594:-KIRCCisplatinEER9.0075e-06-0.2244image
ENSG00000102158.18,MAGT1KIRCCisplatinEAG8.9499e-06-0.2245image
chrX:77827453-77828594:-KIRPGDC.0449EER3.8146e-04-0.2112image
ENSG00000102158.18,MAGT1KIRPGDC.0449EAG3.8146e-04-0.2112image
ENSG00000102158.18,MAGT1LAMLAKT.inhibitor.VIIIEAG7.9111e-030.2183image
chrX:77827453-77828594:-LAMLCCT018159EER2.8728e-020.1804image
ENSG00000102158.18,MAGT1LGGAxitinibEAG2.2396e-080.2410image
chrX:77827453-77828594:-LGGKU.55933EER6.4762e-09-0.2503image
ENSG00000102158.18,MAGT1LIHCBleomycinEAG2.6076e-160.4163image
chrX:77827453-77828594:-LIHCBleomycinEER2.0554e-160.4176image
chrX:77827453-77828594:-LUADCCT018159EER1.1358e-04-0.1693image
ENSG00000102158.18,MAGT1LUADCCT018159EAG1.1596e-04-0.1690image
ENSG00000102158.18,MAGT1LUSCAZD.2281EAG5.3122e-08-0.2410image
chrX:77827453-77828594:-LUSCAZD.2281EER5.3122e-08-0.2410image
chrX:77827453-77828594:-MESOAZD7762EER3.7261e-030.3169image
ENSG00000102158.18,MAGT1MESOAZD7762EAG3.7261e-030.3169image
chrX:77827453-77828594:-OVCytarabineEER5.0741e-060.2638image
ENSG00000102158.18,MAGT1OVCytarabineEAG4.2983e-060.2657image
ENSG00000102158.18,MAGT1PAADAZD8055EAG1.4592e-040.2817image
chrX:77827453-77828594:-PAADAZD8055EER1.4592e-040.2817image
ENSG00000102158.18,MAGT1PCPGAZD6482EAG1.0523e-020.1929image
chrX:77827453-77828594:-PCPGAZD6482EER1.0523e-020.1929image
chrX:77827453-77828594:-PRADGNF.2EER1.9831e-05-0.1909image
ENSG00000102158.18,MAGT1PRADGNF.2EAG1.7326e-05-0.1922image
chrX:77827453-77828594:-READCGP.60474EER1.5935e-03-0.3196image
ENSG00000102158.18,MAGT1READCGP.60474EAG1.5935e-03-0.3196image
ENSG00000102158.18,MAGT1SARCAG.014699EAG3.2153e-080.3396image
chrX:77827453-77828594:-SARCAG.014699EER3.2153e-080.3396image
ENSG00000102158.18,MAGT1SKCMGNF.2EAG7.8099e-09-0.2642image
chrX:77827453-77828594:-SKCMGNF.2EER9.6480e-09-0.2626image
ENSG00000102158.18,MAGT1STADCisplatinEAG2.2294e-03-0.1585image
chrX:77827453-77828594:-STADJNK.Inhibitor.VIIIEER2.8870e-03-0.1545image
ENSG00000102158.18,MAGT1TGCTMG.132EAG4.8873e-070.3958image
chrX:77827453-77828594:-TGCTMG.132EER4.8873e-070.3958image
chrX:77827453-77828594:-THCACytarabineEER1.5661e-050.1915image
ENSG00000102158.18,MAGT1THCACytarabineEAG1.5661e-050.1915image
ENSG00000102158.18,MAGT1THYMCGP.082996EAG2.3759e-050.4054image
chrX:77827453-77828594:-THYMCGP.082996EER2.3759e-050.4054image
chrX:77827453-77828594:-UCECA.770041EER1.9449e-20-0.6347image
ENSG00000102158.18,MAGT1UCECA.770041EAG1.4630e-18-0.6080image
chrX:77827453-77828594:-UCSCGP.60474EER7.6564e-05-0.5034image
ENSG00000102158.18,MAGT1UCSCGP.60474EAG7.2950e-05-0.5047image
chrX:77827453-77828594:-UVMEpothilone.BEER5.5423e-050.4454image
ENSG00000102158.18,MAGT1UVMEpothilone.BEAG5.5423e-050.4454image


Top

check button EAGs targeted by drugs from DrugBank database.
* EAG: EER-associated genes.
EERENSTUniprotIDDrugBankIDDrugDrugType